Luca Valenti
Università degli Studi di Milano
H-index: 93
Europe-Italy
Top articles of Luca Valenti
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease | Hepatology | Alfredo Marchetti Serena Pelusi Alessio Marella Francesco Malvestiti Antony Ricchiuti | 2024/3/11 |
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis | Khaled Abdalla Abdelbaseer Abdalla Eliew Mohamed Ali Hussein Gamal Mohammed Hussein Eman Ahmed Abd-Elmawgood | 2023/1/1 | |
Prevalence and determinants of liver disease in relatives of Italian patients with advanced MASLD | Clinical Gastroenterology and Hepatology | Serena Pelusi Luisa Ronzoni Jessica Rondena Chiara Rosso Grazia Pennisi | 2024/1/11 |
Implementation of a liver health check in people with type 2 diabetes | Kushala WM Abeysekera Luca Valenti Zobair Younossi John F Dillon Alina M Allen | 2024/1/1 | |
Evaluation of ChatGPT as a counselling tool for Italian-speaking MASLD patients: assessment of accuracy, completeness and comprehensiveness | Digestive and Liver Disease | N Pugliese D Polverini R Lombardi G Pennisi F Ravaioli | 2024/2/1 |
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models | Journal of Hepatology | Elisabetta Caon Maria Martins Harry Hodgetts Lieke Blanken Maria Giovanna Vilia | 2024/2/15 |
ABCC2 p. R393W variant contributes to Dubin-Johnson syndrome by targeting MRP2 to proteasome degradation | eGastroenterology | Rong-Yue Sun Yi-Ming Chen Mian-Mian Zhu Ji-an Sun Hong-Wei Wang | 2024/3/1 |
OC. 05.2: FIRST AND FURTHER LIVER DECOMPENSATION IN PATIENTS WITH METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: WHAT CLINICAL IMPACT? | Digestive and Liver Disease | G Pennisi M Viganò AL Fracanzani L Miele E Bugianesi | 2024/4/1 |
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease | Gut | Angelo Armandi Tiziana Sanavia Ramy Younes Gian Paolo Caviglia Chiara Rosso | 2024/1/10 |
Implications of the evolving knowledge of the genetic architecture of MASLD | Luca VC Valenti Vittoria Moretti | 2024/1 | |
A global action agenda for turning the tide on fatty liver disease | Hepatology | Jeffrey V Lazarus Henry E Mark Alina M Allen Juan Pablo Arab Patrizia Carrieri | 2024/2/1 |
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease | Stefano Romeo Oveis Jamialahmadi Antonio De Vincentis Federica Tavaglione Francesco Malvestiti | 2024/2/6 | |
Correction to: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology,(2023), 19, 5,(299-310), 10.1038/s41574 … | Luca Valenti Elena Corradini Leon A Adams Elmar Aigner Saleh Alqahtani | 2024/3 | |
The contribution of genetics and epigenetics to MAFLD susceptibility | Vittoria Moretti Stefano Romeo Luca Valenti | 2024/4/25 | |
Accuracy, reliability, and comprehensibility of chatgpt-generated medical responses for patients with nonalcoholic fatty liver disease | Clinical Gastroenterology and Hepatology | Nicola Pugliese Vincent Wai-Sun Wong Jörn M Schattenberg Manuel Romero-Gomez Giada Sebastiani | 2024/4/1 |
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger | J Clin Images Med Case Rep | G Gallina G Gobbin T D’Aliberti L Ronzoni L Valenti | 2024 |
SIRT5 rs12216101 T> G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease | Journal of Hepatology | Federico Salomone Rosaria Maria Pipitone Miriam Longo Francesco Malvestiti Angela Maria Amorini | 2024/1/1 |
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p. I148M variant drives fatty liver disease susceptibility in women | Nature medicine | Alessandro Cherubini Mahnoosh Ostadreza Oveis Jamialahmadi Serena Pelusi Eniada Rrapaj | 2024/1/24 |
PNPLA3 p. I148M variant affects lipid droplets number and size in patient-derived liver organoids | Digestive and Liver Disease | E Casirati A Cherubini L Cerami D Prati D Dondossola | 2024/2/1 |
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy | Journal of Infection and Public Health | Andrea Lombardi Simone Villa Marta Colaneri Giovanni Scaglione Francesca Bai | 2024/3/1 |
Co-Authors
